» Authors » Wen-Xiu Han

Wen-Xiu Han

Explore the profile of Wen-Xiu Han including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 164
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang Y, Wu J, Zhao Y, Sui W, Tian T, Han W, et al.
Prev Med . 2024 Oct; 189:108147. PMID: 39368643
Objective: Gastrointestinal cancers are one of the most frequent cancer types and seriously threaten human life and health. Recent studies attribute the occurrence of gastrointestinal cancers to both genetic and...
2.
Wang J, Sui W, Zhao Y, Meng S, Han W, Ni J
J Gastroenterol Hepatol . 2024 Jul; 39(11):2332-2339. PMID: 38981855
Background And Aim: Insomnia has been implicated in gastrointestinal diseases (GIs), but the causal effect between insomnia and GIs and underlying mechanisms remain unknown. Methods: By using the released summary-level...
3.
Wang J, Luo G, Tian T, Zhao Y, Meng S, Wu J, et al.
Psychol Med . 2024 Apr; 54(10):2658-2668. PMID: 38563283
Background: The comorbidity between schizophrenia (SCZ) and inflammatory bowel disease (IBD) observed in epidemiological studies is partially attributed to genetic overlap, but the magnitude of shared genetic components and the...
4.
Wei Z, Zhou B, Wang G, Han W, Li Y, Xu A
Int J Clin Oncol . 2023 Dec; 29(2):149-158. PMID: 38112831
Background: Early diagnosis and treatment are crucial to improve the prognosis of colorectal cancer (CRC). At present, there is a lack of an accurate CRC screening factor. We conducted folate...
5.
Li C, Chen Z, Chen P, Meng L, Sui W, Ying S, et al.
World J Gastrointest Oncol . 2023 Sep; 15(9):1673-1674. PMID: 37746649
[This corrects the article on p. 1968 in vol. 14, PMID: 36310707.].
6.
Zhang L, Cao Z, Li H, Li C, Li A, Luo P, et al.
J Investig Med . 2023 Jul; 71(7):782-790. PMID: 37477004
Prediction of prognosis after radical resection of gastric cancer has not been well established. Therefore, we aimed to establish a prognostic model based on a new score system of patients...
7.
Luo P, Zhang L, Chen Z, Wang G, Zhu H, Ying S, et al.
Cell Cycle . 2023 Jun; 22(12):1463-1477. PMID: 37272203
Background: The incidence of gastric cancer (GC) ranks fourth among all malignant tumors worldwide, and the fatality rate ranks second among all malignant tumors. Several Chinese traditional medicines have been...
8.
Song E, Xia H, Zhang L, Ma J, Luo P, Yang L, et al.
World J Gastrointest Surg . 2023 Apr; 15(3):430-439. PMID: 37032799
Background: Gastric cancer (GC) is one of the most common malignant tumors. After resection, one of the major problems is its peritoneal dissemination and recurrence. Some free cancer cells may...
9.
Luo P, Song E, Liu F, Rankine A, Zhang L, Wei Z, et al.
World J Gastrointest Surg . 2023 Feb; 15(1):49-59. PMID: 36741063
Background: Nearly 66% of occurrences of gastric cancer (GC), which has the second-highest death rate of all cancers, arise in developing countries. In several cancers, the predictive significance of inflammatory...
10.
Li C, Chen Z, Chen P, Meng L, Sui W, Ying S, et al.
World J Gastrointest Oncol . 2022 Oct; 14(10):1968-1980. PMID: 36310707
Background: Interleukin (IL)-34 is a pro-inflammatory cytokine involved in tumor development. The role of IL-34 in the proliferation and epithelial-mesenchymal transition (EMT) of gastric cancer (GC) remains to be investigated....